Search Results - E. Nasonov

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study

    Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor in... by E. Feist, S. Fatenejad, S. Grishin, E. Korneva, M.E. Luggen, E. Nasonov, M. Samsonov, J.S. Smolen, R.M. Fleischmann

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial

    Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial by Cyrus Cooper, J-Y Reginster, R Chapurlat, C Christiansen, H Genant, N Bellamy, W Bensen, F Navarro, J Badurski, E Nasonov, X Chevalier, P N Sambrook

    Published 2013-12-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial

    Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial by Jean-Yves Reginster, J Badurski, N Bellamy, W Bensen, R Chapurlat, X Chevalier, C Christiansen, H Genant, F Navarro, E Nasonov, P N Sambrook, T D Spector, C Cooper

    Published 2014-02-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: